OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18

Showing 18 citing articles:

Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11

Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys
Jeffrey M. Rogers, Kayla Colvin, David H. Epstein, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6

Home Care and the Patient Taking Kratom
Heidi Sykora
Home Healthcare Now (2025) Vol. 43, Iss. 2, pp. 122-124
Closed Access

Prevalence and Use Patterns of Kratom ( Mitragyna speciosa Korth.) in a US Nationally Representative Sample
Oliver Grundmann, MeShell Green, Erin C. Berthold, et al.
Journal of Psychoactive Drugs (2025), pp. 1-9
Closed Access

Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report
Oliver Grundmann, Kirsten E Smith, Walter C. Prozialeck, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3

Kratom as a potential substance use disorder harm reduction agent
MeShell Green, Nina Vadiei, Charles A. Veltri, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1

Beneficial and Adverse Health Effects of Kratom (Mitragyna speciosa): A Critical Review of the Literature
J. Thomas Heywood, S. Smallets, Dennis J. Paustenbach
Food and Chemical Toxicology (2024) Vol. 192, pp. 114913-114913
Closed Access | Times Cited: 1

Dynamic Topic Modeling of Kratom Use and Experiences: Insights on 13 years of Reddit Discussions
Seraphina Fong, Alessandro Carollo, Elisabeth Prevete, et al.
(2024)
Open Access | Times Cited: 1

Time course of kratom effects via ecological momentary assessment, by product type, dose amount, and assayed alkaloid content
Kirsten E. Smith, Leigh V. Panlilio, Abhisheak Sharma, et al.
Drug and Alcohol Dependence (2024) Vol. 264, pp. 112460-112460
Open Access | Times Cited: 1

The prevalence of kratom use and association with co-occurring substance use among adolescents: a 2022 Bangkok behavioral surveillance survey, Thailand
Bang‐on Thepthien, Isareethika Jayasvasti, Eunyoung Ham
Journal of Ethnicity in Substance Abuse (2024), pp. 1-15
Closed Access

Kratom – vom natürlichen Heilmittel zur Suchtdroge und zurück
Christian P. Müller, Yuting Yang, Darshan Singh, et al.
Der Nervenarzt (2024) Vol. 95, Iss. 9, pp. 824-829
Closed Access

Elemental impurities (heavy metals) in kratom products: an assessment of published individual product analyses
Kimberly Snow Caroti, Alen Joseph, Amy Sapowadia, et al.
Clinical Toxicology (2024) Vol. 62, Iss. 10, pp. 651-660
Closed Access

Kratom Consumption – The Tales of Three Patients
Samantha A. Gnanasegaram, Leslie K. Sexton, Corneliu N. Stanciu
Journal of Psychoactive Drugs (2024), pp. 1-4
Closed Access

Aggression in a Cohort of Male Methamphetamine (METH) Users With and Without Kratom ( Mitragyna speciosa Korth.) Use History in Malaysia
Yuting Yang, Christian P. Müller, Darshan Singh
Journal of Psychoactive Drugs (2024), pp. 1-12
Closed Access

The rise of novel, semi‐synthetic 7‐hydroxymitragnine products
Kirsten E. Smith, Edward W. Boyer, Oliver Grundmann, et al.
Addiction (2024)
Closed Access

Use Patterns of Classic, Novel, and Herbal Opioids
Elisabeth Prevete, Natasha L. Mason, Kim P. C. Kuypers, et al.
Emerging Trends in Drugs Addictions and Health (2024), pp. 100166-100166
Open Access

An exploratory study of the safety profile and neurocognitive function after single doses of mitragynine in humans
Elisabeth Prevete, Eef L. Theunissen, Kim P. C. Kuypers, et al.
Psychopharmacology (2024)
Open Access

Page 1

Scroll to top